Medical News

RSS

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe. The study, which was initiated in August 2009 in the Southern Hemisphere, is designed to investigate Adamas' triple combination antiviral drug (TCAD) therapy as a treatment for influenza A, including novel influenza A/H1N1, the cause of the current flu pandemic.

19 Nov 2009

Senate leaders consider timeline for health bill votes

Roll Call reports: "Senators may keep slogging through debate on their health care overhaul until the day before Thanksgiving, according to an adjournment resolution the House approved Wednesday. That measure provided for the Senate to adjourn Friday — or next Wednesday. The House is set to break on Thursday or Friday of this week." The Senate must first vote on a motion to proceed - to move the bill to the floor (Newmyer, 11/18).

19 Nov 2009

Anika Therapeutics' "ELEVESS Light" receives European CE Mark approval

Anika Therapeutics, Inc., a leader in products for tissue protection, healing and repair based on hyaluronic acid (“HA”) technology, today announced that it has received European CE Mark approval for “ELEVESS™ Light,” the Company’s latest aesthetic product used for the treatment of fine lines and facial wrinkles. ELEVESS Light will be distributed in the European market by the Company’s current aesthetic dermatology distributors.

19 Nov 2009

Kansas pilot program to use electronic medical records to coordinate care

A health information technology project "may revolutionize how health care is managed" by using medical records to coordinate patients' records.

19 Nov 2009

WaferGen Biosystems launches new SmartChip Service for gene-expression profiling of thousands of genes

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced a new, innovative service for gene-expression profiling of thousands of genes using the SmartChip(TM) Real-Time PCR System. By taking advantage of the SmartChip Real-Time PCR system, WaferGen will offer universities, pharmaceutical and diagnostic companies a service that utilizes pathway-specific gene panels to discover and validate new biomarkers.

19 Nov 2009

White House backing Medicare 'doc fix' bill

Reuters reports that the White House Wednesday "urged Congress to pass a bill to boost Medicare payments to doctors, a step that could shore up support" from the American Medical Association for health care reform.

19 Nov 2009

Lawmakers call for inquiry into pharmaceutical company price hikes

Congressional Democrats are seeking government investigations into recent price increases of brand-name prescription drugs, as Congress finalizes an overhaul of the healthcare system. Lawmakers are concerned the companies are trying to reap gains ahead of reforms aimed at lowering drug prices and forcing drugmakers to partly fund changes that aim to boost the number of Americans covered by health insurance.

19 Nov 2009

VisEn Medical launches two new agents for imaging quantification

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.

19 Nov 2009

Emerging trends fuelling the US market for reprocessed electrophysiology diagnostic catheters

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for reprocessed electrophysiology diagnostic catheters will grow at a rate of over 15% through 2014. MRG's new US Markets for Electrophysiology Mapping and Ablation Devices 2010 report finds that although reprocessed catheters have existed for a number of years, it is only recently that this device type has begun to play a larger role in the electrophysiology diagnostic market.

19 Nov 2009

Positive results from Echo Therapeutics' Symphony tCGM System study

Echo Therapeutics, Inc., a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes.

19 Nov 2009

Cardiovascular Systems commences patient enrollment in CALCIUM 360° clinical trial

Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI’s Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.

19 Nov 2009

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.

19 Nov 2009

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

19 Nov 2009

Dicom Systems' latest API improves the Teleradiology network experience for healthcare professionals

Dicom Systems, consolidating their reputation for continued and groundbreaking innovation, are preparing to launch the latest addition to their DCMSYS family: API for Advanced Statistical reports and graphs, and for monitoring.

19 Nov 2009

ISCO, Scripps Research Institute collaborate in study of parthenogenetic stem cells

International Stem Cell Corporation, announced today that it is collaborating with renowned stem cell researcher Jeanne F. Loring, Ph.D., and the Scripps Research Institute (La Jolla, CA) to study parthenogenetic stem cells and potentially therapeutic cells that can be derived from them.

19 Nov 2009

Patterson announces second-quarter fiscal 2010 operating results

Patterson Companies, Inc. today reported consolidated sales of $814,951,000 for the second quarter of fiscal 2010 ended October 24, an increase of 7% from $759,461,000 in the year-earlier quarter. Acquisitions transacted over the past 12 months accounted for a substantial portion of the second quarter sales growth, while the impact of foreign currency adjustments was minimal.

19 Nov 2009

Interim data from Geron's ongoing imetelstat trial presented at the AACR-NCI-EORTC conference

Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat (GRN163L), a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.

19 Nov 2009

VCU-RAA treatment protocol nearly doubles pre-hospital cardiac arrest resuscitation and survival rates

ZOLL Medical Corporation announced today that in a “Best Original Resuscitation Science” presentation at the American Heart Association’s Resuscitation Science Symposium (ReSS) in Orlando Florida, Joseph P. Ornato, M.D., and Mary Ann Peberdy, M. D., reported nearly doubling the resuscitation and survival rates from out-of-hospital cardiac arrest due to a comprehensive treatment protocol established between Virginia Commonwealth University Medical Center (VCU) and the Richmond Ambulance Authority (RAA).

19 Nov 2009

TrinityCare Senior Living executes $1.65 million investment agreement by RCHP

TrinityCare Senior Living, Inc. (OTCBB: TCSR), which develops, manages and owns faith-based senior living facilities, today announced the execution of a $1.65 million investment agreement by RCHP, LLC, a Texas-based boutique investment firm.

19 Nov 2009

SinoFresh Nasal Spray effective against 'swine flu' in animal study

SinoFresh Healthcare Products, Inc. announced today the successful results of its initial pilot animal study testing the efficacy of the SinoFresh Nasal Spray product when used on animals infected with the H1N1 virus. The study data suggests that treatment with SinoFresh allowed the infected animals to recover more rapidly from H1N1 infection than did untreated animals. In addition, pre-treatment with SinoFresh Nasal Spray decreased the severity and/or incidence of infection.

19 Nov 2009

Medical News

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Senate leaders consider timeline for health bill votes

Anika Therapeutics' "ELEVESS Light" receives European CE Mark approval

Kansas pilot program to use electronic medical records to coordinate care

WaferGen Biosystems launches new SmartChip Service for gene-expression profiling of thousands of genes

White House backing Medicare 'doc fix' bill

Lawmakers call for inquiry into pharmaceutical company price hikes

VisEn Medical launches two new agents for imaging quantification

Emerging trends fuelling the US market for reprocessed electrophysiology diagnostic catheters

Positive results from Echo Therapeutics' Symphony tCGM System study

Cardiovascular Systems commences patient enrollment in CALCIUM 360° clinical trial

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

Dicom Systems' latest API improves the Teleradiology network experience for healthcare professionals

ISCO, Scripps Research Institute collaborate in study of parthenogenetic stem cells

Patterson announces second-quarter fiscal 2010 operating results

Interim data from Geron's ongoing imetelstat trial presented at the AACR-NCI-EORTC conference

VCU-RAA treatment protocol nearly doubles pre-hospital cardiac arrest resuscitation and survival rates

TrinityCare Senior Living executes $1.65 million investment agreement by RCHP

SinoFresh Nasal Spray effective against 'swine flu' in animal study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News